The SARS-COV2 (COVID-19) Pandemic: What Clinicians should Know
Afro-Egypt. j. infect. enem. dis
;
10(2): 65-92, 2022. tables, figures
Artículo
en Inglés
| AIM
| ID: biblio-1426651
ABSTRACT
In late 2019, a novel coronavirus, now designated SARS-CoV-2, emerged and was identified as the cause of an outbreak of acute respiratory illness in Wuhan, a city in China, named as COVID-19. Since then the waves of the virus exponentially hit many countries around the globe with high rates of spread associated with variable degrees of morbidity and mortality. The WHO announced the pandemic state of the infection in March 2020 and by June 1st 2020 more than 6 million individuals and more than 370 thousands case fatalities were documented worldwide. In this article, we discussed many aspects regarding this emerged infection based on the available evidence aiming to help clinician to improve not only their knowledge but also their practices toward this infection.
Texto completo:
Disponible
Índice:
AIM (África)
Asunto principal:
Indicadores de Morbimortalidad
/
Prueba de Ácido Nucleico para COVID-19
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Afro-Egypt. j. infect. enem. dis
Año:
2022
Tipo del documento:
Artículo
Institución/País de afiliación:
Clinical Program, Faculty of Pharmacy, Zagazig University, Zagzig/EG
/
Department of Dermatology, Venereology and Andrology, Faculty of Medicine/EG
/
Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine/EG
/
Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Kafrelshiekh University/EG
/
Department of Radiology, Faculty of Medicine, Kafrelshiekh University, Kafr Elshikh/EG
/
Department of Tropical Medicine, Faculty of Medicine, Zagazig University/EG
/
Department of Tropical Medicine, Faculty of Medicine, Zagazig/EG
Similares
MEDLINE
...
LILACS
LIS